Iclusig®
Showing 1 - 25 of >10,000
Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any
Active, not recruiting
- Chronic Myeloid Leukemia, Chronic Phase
-
Jena, GermanyUniversity Hospital Jena
Jan 17, 2023
Iclusig PMS in CML or Ph+ALL Patients
Recruiting
- Chronic Myeloid Leukemia
- Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
-
Busan, Korea, Republic ofKosin University Gaspel Hospital
Sep 16, 2021
Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)
Terminated
- Chronic Phase Chronic Myeloid Leukemia
- Ponatinib 30 mg QD
- +2 more
-
Bruxelles, BelgiumCliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021
Leukemia, Myeloid, Acute Trial in France (Ponatinib 30 MG)
Recruiting
- Leukemia, Myeloid, Acute
- Ponatinib 30 MG
-
Angers, France
- +13 more
Aug 4, 2021
Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,
Recruiting
- Lymphoblastic Leukemia
- +2 more
- Inotuzumab ozogamicin
- +7 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
May 16, 2022
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Active, not recruiting
- Chronic Myeloid Leukemia
-
Saint-Pierre, Reunion, France
- +39 more
Dec 13, 2021
Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)
Active, not recruiting
- Acute Lymphoblastic Leukemia, Adult
- +2 more
- Ponatinib 15 MG Oral Tablet
-
Brno, Czechia
- +6 more
Nov 30, 2022
Vascular Occlusive Events Associated With ICLUSIG®
Terminated
- Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
-
Hackensack, New Jersey
- +1 more
Oct 30, 2020
Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora
Completed
- Adenocarcinoma of the Lung
- +7 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 19, 2022
Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)
Active, not recruiting
- Leukemia, Myeloid, Chronic-Phase
-
Halle (Saale), Saxony-Anhalt, Germany
- +9 more
Sep 9, 2022
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic
Active, not recruiting
- Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Dexamethasone
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 2, 2022
Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)
Not yet recruiting
- Chronic Myeloid Leukemia (CML)
- Ponatinib 15mg QD
- Ponatinib 30mg QD
-
Cagliari, Italy
- +12 more
Jan 31, 2021
Malignant Tumor Trial in Ann Arbor, Columbus (ponatinib HCl, laboratory biomarker analysis)
Unknown status
- Malignant Neoplasm
- ponatinib hydrochloride
- laboratory biomarker analysis
-
Ann Arbor, Michigan
- +1 more
Feb 14, 2020
Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in China (Ponatinib)
Recruiting
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
-
Hefei, Anhui, China
- +13 more
Aug 11, 2020
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2022
Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)
Completed
- Chronic Myeloid Leukemia
- Ph+ Acute Lymphoblastic Leukemia
-
St Leonards, New South Wales, Australia
- +41 more
Jan 18, 2021
Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)
Active, not recruiting
- Myeloid Leukemia, Chronic, Chronic Phase
-
Atlanta, Georgia
- +85 more
Jan 4, 2022
Ponatinib in BCR-ABL Positive ALL in Standard Clinical Practice
Withdrawn
- BCR-ABL Positive Acute Lymphoblastic Leukemia
-
Praha, Czechia
- +9 more
Dec 12, 2018
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)
Completed
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Cyclophosphamide
- +16 more
-
Portland, OregonOHSU Knight Cancer Institute
May 21, 2020
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in Israel, United States (Blinatumomab,
Recruiting
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- Blinatumomab
- +10 more
-
Anchorage, Alaska
- +152 more
Aug 11, 2022